Overview
Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study
Status:
Completed
Completed
Trial end date:
2009-11-01
2009-11-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine whether Chinese medicinal herbs are effective and safe for treating novel influenza A (H1N1) infection.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Capital Medical UniversityTreatments:
Antiviral Agents
Oseltamivir
Criteria
Inclusion Criteria:- Confirmed novel influenza A(H1N1) case with laboratory evidence
- 70 years ≥ age ≥ 14years
- Within 72hr after the onset of symptoms(body temperature≥37.5℃ with at least one
respiratory symptom (cough, sore throat, or nasal symptom)
Exclusion Criteria:
- Age < 14 years or > 70 years
- Bronchitis, pneumonia, pleural fluid and interstitial infiltration showed by Chest
radiology(x-ray or CT)
- Severe chronic underlying diseases: severe COPD(FEV1/EVC <70% and FEV1 <30% predicted
or respiratory failure or congestive heart failure), severe hepatic disfunction(ALT or
AST ≥3 times normal elevation), renal disfunction(Cr>2mg/dL), chronic heart
failure(NYHA Ⅲ-Ⅳ grade)
- Immunocompromised patients(cancer, organ transplant, AIDS and a history of treatment
with immunosuppressive drug and glucocorticoids in the past 3 months)
- Taken Chinese medicinal herbs, antiviral or antibiotic drug in the past 2 weeks
- Inoculation influenza vaccination
- One of the following items appeared at the enrollment
- respiratory failure:PaO2<60mmHg and/or PCO2>50mmHg or PaO2/FiO2≤300
- circulation failure: despite adequate fluid resuscitation and cardiac output,
systolic <90mmHg or requirement inotropic support
- renal function failure: despite adequate fluid resuscitation and cardiac output,
urine ≤ 0.5ml/kg.h, Cr or BUN≥1 time normal elevation
- hepatic function failure: total bilirubin>34μmol/L or ALT/AST ≥3 times normal -
Other unappropriated enrollment situations considered by investigator